Tuesday, March 26, 2019

Laurus Labs seals deal with Global Fund to supply ARV combination medicine

Laurus Labs seals deal with Global Fund to supply ARV combination medicine Laurus staved off competition from drug makers such as Mylan, Cipla, Sun Pharma and Macleods to win the contract.

from Moneycontrol Business News https://ift.tt/2Fs6dj0

No comments:

Post a Comment

Paras Defence shares soar 10% as Q2 net profit jumps 50% to Rs 14 crore

Paras Defence and Space Technologies shares surged following strong September quarter results, with net profit jumping 50% and revenue climb...